Feedback / Questions
isomyosamine (MYMD-1) - MyMD Pharma, Akers Biosci
https://www.businesswire.com/news/home/20250416886460/en/TNF-Pharmaceuticals-Delivers-Platform-Presentation-of-Oral-TNF-Alpha-Inhibitor-Isomyosamine-at-British-Geriatrics-Societys-Spring-Meeting-2025
Apr 16, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next